Fetal aortic valvuloplasty for critical aortic stenosis: single‐center retrospective study focusing on postnatal outcome
R. Corroenne, M. Meot, L. J. Salomon, I. Szezepanski, H. Baghdadi, B. Stos, M. Levy, J. Le Bidois, D. Laux, R. Gaudin, O. Raisky, Y. Ville, D. Bonnet, J. Stirnemann, S. Malekzadeh‐Milani- Obstetrics and Gynecology
- Radiology, Nuclear Medicine and imaging
- Reproductive Medicine
- General Medicine
- Radiological and Ultrasound Technology
ABSTRACT
Objective
We aimed to report our experience on fetal aortic valvuloplasty (FAV) for critical aortic stenosis (AS) focusing on the postnatal evolution of the patients.
Methods
This retrospective study was approved by our local Institutional Review Board (n°2002‐0128143827). All fetuses with critical AS who underwent FAV in a single center between 01/2011 and 06/2022 were included. FAV were performed under ultrasound guidance. Technical success was based upon balloon inflation across the aortic valve and improvement of the anterograde aortic flow across the aortic valve. At birth, biventricular circulation (BVC) strategy was decided assuming the left ventricle (LV) systolic and diastolic functions would ensure the systemic circulation.
Results
Sixty‐three FAV were performed on 58 fetuses at 24.6[21.4‐32.4] weeks of gestation. The procedure was successful in 52/58(89.6%) fetuses. There were 11/58(19%) in utero demises and 9/58(15.5%) terminations of pregnancy. There were no liveborn patients after the unsuccessful procedures. 38/58(65.5%) infants were delivered at a median gestational age of 38.1[29‐40.6] weeks and 21/38(55.3%) of them required prostaglandin. 28/38(73.7%) [28/58(48.3%)] children entered the BVC path at birth. Among them, 20 required an aortic valvuloplasty at birth (11 percutaneous, 9 surgical) and 8 did not require any treatment at birth but of those, 5/8 underwent a surgical valvuloplasty between day 26 and day 1200 of life. 11/28(39.3%) infants with BVC at birth required a second intervention and four of them required a third intervention. Two infants who entered the BVC at birth underwent a conversion to UVC. None of the surviving children with BVC developed pulmonary hypertension. The global survival rate in case of BVC was 22/28(78.6%) at 23.3[8‐112] months of life. 10 patients had UVC at birth. Among them, 6 received comfort care from birth and only 4 underwent surgery. 3/10 patients were still alive at the latest assessment (48[22‐102] months).
Conclusion
FAV for critical aortic stenosis led to anterograde aortic flow in 89.6% of the fetuses, with BVC being achieved in 48.3% (73.7% of the live born). Among patients with BVC at birth, the rate of reintervention is high but long‐term survival is satisfactory.
This article is protected by copyright. All rights reserved.